Hormone therapy may cut colorectal cancer risk (Reuters, 8 January 2009)

09 Jan 2009


Women using hormone replacement therapy - particularly a combination of estrogen and progestin - could be at a reduced risk of developing colorectal cancer, according to a new study from the University of Minnesota.

Full article


Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story